In-licensing: Pharmaceuticals For Type 2 Diabetes

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Pharmaceuticals for diabetes type 2; preferably rx status

We are seeking rx products to complement our existing portfolio within type 2 diabetes

At this moment our biggest product within this field is metformin in retard form.

We are looking for DPP-IV inhibitors and other new approaches

Phase III

In-licensing exclusive rights to market and sell products in Finland.

Mr Raimo Skottman
Business Development Director

Leiras Finland Oy

Finnish pharmaceutical company focused upon Rx, OTC and generics.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Industry sector: Biotechnology; Pharmaceutical / Generics; Pharmaceutical; Pharmaceutical / Prescription
Therapeutic target: Cardiovascular; Metabolism / Diabetes type II; Metabolism / Metabolic disorder (other); Metabolism

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.